Comparative performance of AnTicoagulation and Risk factors In Atrial fibrillation and Global Registry of Acute Coronary Events risk scores in predicting long-term adverse events in patients with acute myocardial infarction
We performed a pair-wise comparison of receiver operating characteristic curves,andnoted the predictive value of ATRIA RS with regard to primary endpoints was similar to that of GRACE RS (By DeLong method, AUCATRIA vs.AUCGRACE z test=0.64, p=0.52).Conclusion: ATRIA RS may be useful in predicting prognosis in patients having AMI during long-term follow-up. (
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Objective: This study is designed to evaluate the recently developed AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) risk score(RS), which determines the predisposition to thromboembolic and hemorrhagic events in atrial fibrillation, as a predictor of prognosis in patientshaving acute myocardial infarction (AMI), and to compare the predictive ability of ATRIA RS with GRACE RS.Methods: We analyzed 1627 patients having AMI who underwent coronary angiography and/or percutaneous coronary intervention (PCI) betweenJanuary 2011 and February 2015.
📊
Temel Bulgular & Veri:The primary endpoints included all-cause mortality, non-fatal MI, and cerebrovascular events duringfollow-up.Results: Multivariate Cox regression analysis showed that the ATRIA RS>3 was an independent predictor of major adverse cardiac events inpatients with AMI [hazard ratio, 2.00, 95% confidence interval, 1.54 to 2.60, p<0,001].
💡
Sonuç & Katkı:We performed a pair-wise comparison of receiver operating characteristic curves,andnoted the predictive value of ATRIA RS with regard to primary endpoints was similar to that of GRACE RS (By DeLong method, AUCATRIA vs.AUCGRACE z test=0.64, p=0.52).Conclusion: ATRIA RS may be useful in predicting prognosis in patients having AMI during long-term follow-up. (
🔬Tür:Araştırma Makalesi
📍Kapsam:2011 Verileri
⚙️Değişkenler:Alan Parametreleri
Özet
Objective: This study is designed to evaluate the recently developed AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) risk score(RS), which determines the predisposition to thromboembolic and hemorrhagic events in atrial fibrillation, as a predictor of prognosis in patientshaving acute myocardial infarction (AMI), and to compare the predictive ability of ATRIA RS with GRACE RS.Methods: We analyzed 1627 patients having AMI who underwent coronary angiography and/or percutaneous coronary intervention (PCI) betweenJanuary 2011 and February 2015. The primary endpoints included all-cause mortality, non-fatal MI, and cerebrovascular events duringfollow-up.Results: Multivariate Cox regression analysis showed that the ATRIA RS>3 was an independent predictor of major adverse cardiac events inpatients with AMI [hazard ratio, 2.00, 95% confidence interval, 1.54 to 2.60, p<0,001]. The area under the curve (AUC) for ATRIA RS and GRACERS was 0.66 and 0.67 (p<0.001, and p<0.001), respectively. We performed a pair-wise comparison of receiver operating characteristic curves,andnoted the predictive value of ATRIA RS with regard to primary endpoints was similar to that of GRACE RS (By DeLong method, AUCATRIA vs.AUCGRACE z test=0.64, p=0.52).Conclusion: ATRIA RS may be useful in predicting prognosis in patients having AMI during long-term follow-up. (
🔖
Bu Makaleye Atıf Yap
ÇETİNKAL, G., KOÇAŞ, C., KOÇAŞ, B. B., ARSLAN, Ş., ABACI, O., KARACA, O. Ş., DALGIÇ, Y., SER, Ö. S., KESKİN, K., YILDIZ, A., DOĞAN, S. M. (2018). Comparative performance of AnTicoagulation and Risk factors In Atrial fibrillation and Global Registry of Acute Coronary Events risk scores in predicting long-term adverse events in patients with acute myocardial infarction. The Anatolian Journal of Cardiology, Cilt: 20 - Sayı: 2, 77–84. https://ajindex.com/articles/367293
Capodanno D, Rossini R, Musumeci G, Lettieri C, Senni M, Valsecchi O, et al. Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy. Int J Cardiol. 2015; 199: 319-25. [CrossRef] Hsieh MJ, Lee CH, Chen CC, Chang SH, Wang CY, Hsieh IC. Predictive performance of HAS-BLED risk score for long-term survival in patients with non-ST elevated myocardial infarction without atrial fibrillation. J Cardiol 2017; 69: 136-43. [CrossRef] Sabaté M, Räber L, Heg D, Brugaletta S, Kelbaek H, Cequier A, et al. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials. JACC Cardiovasc Interv 2014; 7: 55-63.
Puymirat E, Aissaoui N, Cayla G, Lafont A, Riant E, Mennuni M, et al. Changes in One-Year Mortality in Elderly Patients Admitted with Acute Myocardial Infarction in Relation with Early Management. Am J Med 2017; 130: 555-63. [CrossRef] Avezum A, Makdisse M, Spencer F, Gore JM, Fox KA, Montalescot G, et al. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2005; 149: 67-73. [CrossRef] Dai X, Busby-Whitehead J, Alexander KP. Acute coronary syndrome in the older adults. J Geriatr Cardiol 2016; 13: 101-8.
Fox KA, Eagle KA, Gore JM, Steg PG, Anderson FA; GRACE and GRACE2 Investigators. The Global Registry of Acute Coronary Events, 1999 to 2009--GRACE. Heart 2010; 96: 1095-101. [CrossRef] Rosengren A, Wallentin L, Simoons M, Gitt AK, Behar S, Battler A, et al. Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. Eur Heart J 2006; 27: 789-95. [CrossRef] Zhu W, Fu L, Ding Y, Huang L, Xu Z, Hu J, et al. Meta-analysis of ATRIA versus CHA2DS2-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation. Int J Cardiol 2017; 227: 436-42. [CrossRef] Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al.; Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, ESC C